Related Experiment Video

Updated: Feb 10, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.7K

Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer

Xiangdong Zhu1,2, Yonghua Bao3, Yongchen Guo4

  • 1Institute of Precision Medicine, Jining Medical University, Jining 272067, China. xiangdon@uic.edu.

Cancers
|May 9, 2018
PubMed

Insights

Focal adhesion kinase-related proline-rich tyrosine kinase 2 (Pyk2) is crucial in cell adhesion and signaling. This review highlights Pyk2

Area of Science:

  • Biochemistry and Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Focal adhesion kinase (FAK) and FAK-related proline-rich tyrosine kinase 2 (Pyk2) are non-receptor tyrosine kinases.
  • They are key regulators of cytoskeletal dynamics, cell adhesion, survival, and growth signaling.

Purpose of the Study:

  • To review the physiological and pathological roles of Pyk2.
  • To emphasize Pyk2's involvement in inflammation and cancer progression.

Main Methods:

  • Literature review of Pyk2's functions.
  • Analysis of Pyk2's role in various oncogenic signaling pathways.

Main Results:

  • Pyk2 overexpression in cancer correlates with poor patient outcomes.
  • Pyk2 promotes carcinogenesis, migration, invasion, epithelial-mesenchymal transition, and metastasis.
  • Pyk2 activates oncogenic pathways including Wnt/β-catenin, PI3K/Akt, MAPK/ERK, and TGF-β/EGFR/VEGF.

Conclusions:

  • Pyk2 plays a significant role in cancer development and progression.
  • Pyk2 represents a valuable therapeutic target with clinical significance in oncology.
Keywords:
EMTFAKPyk2carcinogenesisinflammationmetastasis

More Related Videos

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate11:31

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

10.5K
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

8.4K

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.9K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
Inflammation01:38

Inflammation

Overview
62.3K
Conservation of Protein Domains Over Different Proteins02:26

Conservation of Protein Domains Over Different Proteins

Protein domains are small structurally independent units that are part of a single amino acid chain.  Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
14.6K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
559